课题基金 / 基金详情

The analysis of altered glycosylation in Alzheimer's disease

The analysis of altered glycosylation in Alzheimer's disease
阿尔茨海默氏病糖基化改变的分析
批准号:
22590933
负责人:
URAKAMI Katsuya
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

URAKAMI Katsuya的其他基金

相似基金

相关文献

中文摘要
翻译
We measured the contents of the sugar chain in two glycoproteins which has altered glycosylation in Alzheimer’s disease (AD), one is transferrin and another is the protein associated with immune system, temporally named protein X. We indicated both of them had decreased glycosylation in very early stage of AD. The decreased levels of glucosylation of protein X was correlated with the altered levels of cerebrospinal fluid (CSF) amyloid β protein. The altered sugar chain of protein X in Alzheimer’s serum must be a 優秀な biological marker for diagnosis of AD, that monitors the change in the brain or CSF derived from the brain. On the other way, we also found the decreased levels of a-2, 6-sialyltransferase (STase) in Alzheimer’s serum. STase is the enzyme which adds the sialic acid to the transferrin. This indicates the decreased sialylation of Alzheimer’s serum transferrin is 原因であるby the altered STase. These two changes in glycoproteins suggest the 異常なglycosylation 密接にassociates the pathophysiology of AD
英文摘要
We measured the contents of the sugar chain in two glycoproteins which has altered glycosylation in Alzheimer’s disease (AD), one is transferrin and another is the protein associated with immune system, temporally named protein X. We indicated both of them had decreased glycosylation in very early stage of AD. The decreased levels of glucosylation of protein X was correlated with the altered levels of cerebrospinal fluid (CSF) amyloid β protein. The altered sugar chain of protein X in Alzheimer’s serum must be a 優秀な biological marker for diagnosis of AD, that monitors the change in the brain or CSF derived from the brain. On the other way, we also found the decreased levels of a-2, 6-sialyltransferase (STase) in Alzheimer’s serum. STase is the enzyme which adds the sialic acid to the transferrin. This indicates the decreased sialylation of Alzheimer’s serum transferrin is 原因であるby the altered STase. These two changes in glycoproteins suggest the 異常なglycosylation 密接にassociates the pathophysiology of AD
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
認知症診療に必要な基礎知識
痴呆症治疗所需的基础知识
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Ago T, et al, Chikako Nito, 浦上克哉]
通讯作者: 浦上克哉
認知症検診と予防介入~ライフスタイルの観点から~
痴呆症筛查和预防干预 - 从生活方式的角度 -
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [仁藤智香子, 片山泰朗, 浦上克哉]
通讯作者: 浦上克哉
認知症は怖くない 18のワケ
痴呆症并不可怕的 18 个理由
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Kamihira S., Yamano Y., Iwanaga M., et al., 三宅彩香,他, 朝倉邦彦, 浦上克哉, 三木康生,冨山誠彦,新井陽ほか8名, 村上真樹,他, 浦上克哉]
通讯作者: 浦上克哉
要支援高齢者の認知機能とADL,介護負担感の関連における在宅支援の検討
检查与需要支持的老年人的认知功能、ADL 和护理负担感相关的家庭支持
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [崎山佑介, 大窪隆一, 西郷隆二, 徳永章子, 平野隆城, 山下秀一, 塩見一剛, 高嶋 博, 宮崎育子,他, 古川芳明, 福田敏秀]
通讯作者: 福田敏秀
共 60 条
    Dementia Prevention - Early Detection by Olfactory Function Test and Prevention by Aromatherapy
    • 批准号:
      20K07886
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      URAKAMI Katsuya
    • 依托单位:
    Clinical utilization of β-Acl, newly identified Aβ associated protein, as a novel diagnostic marker of Alzheimer's disease.
    • 批准号:
      18590940
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2006
    • 负责人:
      URAKAMI Katsuya
    • 依托单位:
    Analysis of the relationship between Amyloid β protein and cholesterol in Alzheimer's disease.
    Abnormality of free radical scavenging mechanism in skin fibroblasts with dementia of the Alzheimer type
    • 批准号:
      05670558
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1993
    • 负责人:
      URAKAMI Katsuya
    • 依托单位:
    海外基金